BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/6/2016 8:46:00 PM | Browse: 450 | Download: 444
Publication Name World Journal of Nephrology
Manuscript ID 20286
Country/Territory Greece
2015-06-01 15:53
Peer-Review Started
2015-06-04 18:03
To Make the First Decision
2015-08-14 15:24
Return for Revision
2015-08-22 17:32
2015-09-23 04:21
Second Decision
2015-10-13 08:59
Accepted by Journal Editor-in-Chief
2015-10-13 15:03
Accepted by Company Editor-in-Chief
2015-10-27 17:59
Articles in Press
2015-10-27 17:59
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2015-12-28 16:39
Publish the Manuscript Online
2016-01-06 20:46
ISSN 2220-6124 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Urology and Nephrology
Manuscript Type Editorial
Article Title Receptor activator of nuclear factor κB ligand/osteoprotegerin axis and vascular calcifications in patients with chronic kidney disease
Manuscript Source Invited Manuscript
All Author List Michalis Spartalis and Aikaterini Papagianni
Funding Agency and Grant Number
Corresponding author Aikaterini Papagianni, MD, PhD, Associate Professor, Department of Nephrology, Aristotle University of Thessaloniki, “Hippokration” General Hospital, Papanastasiou 50 Str, 54642 Thessaloniki, Greece. aikpapag@otenet.gr
Keywords Arterial stiffness; Bone turnover; Chronic kidney disease; Osteoprotegerin; RANK ligand; Receptor activator nuclear factor κB; Vascular calcifications
Core Tip Vascular calcifications are commonly observed in chronic kidney disease patients and recently mounting evidence suggest that Receptor activator of nuclear factor κB ligand/osteoprotegerin axis controls both bone metabolism and extra-osseous bone formation. Further studies are required to establish the role of these biomarkers as predictors of the presence and severity of vascular calcifications and of cardiovascular morbidity and mortality. Moreover, randomized clinical trials are needed to clarify whether inhibition of osteoclast activity will protect from vascular calcifications.
Publish Date 2016-01-06 20:46
Citation Spartalis M, Papagianni A. Receptor activator of nuclear factor κB ligand/osteoprotegerin axis and vascular calcifications in patients with chronic kidney disease. World J Nephrol 2016; 5(1): 1-5
Url http://www.wjgnet.com/2220-6124/full/v5/i1/1.htm
DOI http://dx.doi.org/10.5527/wjn.v5.i1.1
Full Article (PDF) WJN-5-1.pdf
Full Article (Word) WJN-5-1.doc
Manuscript File 20286-Review.doc
Answering Reviewers 20286-Answering reviewers.pdf
Audio Core Tip 20286-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 20286-Conflict-of-interest statement.pdf
Copyright License Agreement 20286-Copyright assignment.pdf
Peer-review Report 20286-Peer-review(s).pdf
Journal Editor-in-Chief Review Report 20286-Journal editor-in-chief review report.pdf
Scientific Misconduct Check 20286-Scientific misconduct check.pdf
Scientific Editor Work List 20286-Scientific editor work list.pdf